创远信科(831961) - 2023 Q4 - 年度业绩

Financial Performance - The total revenue for 2023 was CNY 270,082,290.88, a decrease of 15.07% compared to the previous year[4] - Net profit attributable to shareholders increased to CNY 33,874,428.48, representing a growth of 52.11% year-on-year[4] - The net profit after deducting non-recurring gains and losses was CNY 16,125,218.23, showing a significant increase of 515.76% compared to the previous year[4] - Basic earnings per share rose to CNY 0.24, reflecting a 50.00% increase year-on-year[4] Assets and Equity - Total assets at the end of the reporting period were CNY 1,178,463,842.67, up 12.53% from the beginning of the year[5] - Shareholders' equity attributable to the parent company increased to CNY 746,215,838.49, a growth of 5.25% year-on-year[5] Operational Developments - The company launched a series of new products in 2023, contributing to improved gross margins[8] - Sales, management, and R&D expenses decreased due to reduced stock incentive costs and lower R&D investments[8] - The company’s equity investments performed better year-on-year, leading to reduced investment losses[8] Cautionary Notes - The financial data presented is preliminary and has not been audited, cautioning investors about potential risks[9]